Thursday, April 23, 2026

Pre-conference: Hereditary Hematologic Cancers Primer and Case-Based Workshop

Location: Renaissance Ballroom

8:00am-8:10am
Welcome, Introductions, Overview
Kathleen Blazer, Director & Jane Churpek, MD, MS, Program Chair

8:10am-8:20am
Basics of Hematology Relevant to Germline Genetic Testing
Jane Churpek, MD, MS

8:20am-8:35am
Indications and Guidelines for Germline Testing in Patients with Hematologic Malignancies/Disorders Christopher Reilly, MD

8:35am-8:50am
New Horizons in Genetic Test and Sample Type Selection for Hereditary Hematologic Malignancy Syndromes
Lauren Banaszak, MD

8:50am-9:05am
Updates on Variant Curation and Interpretation for Hematologic Malignancy Predisposition Disorders
Lucy Godley, MD

9:05am-9:35am
Implementing a Hereditary Hematology Program
Raymond Kim, MD, and Brittany Stewart, MS, CGC

9:35am-9:50am
Q&A/Participant and Panel Discussion

9:50am-10:00am
Break

10:00am-10:55am
Putting It All Together: Team-Based Learning (TBL) Part 1: Breakout Sessions

Faculty Panel: Jane Churpek, MD, MS, Christopher Reilly, MD, Lauren Banaszak, MD, Lucy Godley, MD, Raymond Kim, MD, and Brittany Stewart, MS, CGC

Moderators: Emma Adams, MS, CGC, Alex Capasso, MS, CGC, Lauren Gima, MS, Bita Nehoray, MS, GCG Elise Sobotka, MS, MPH, CGC, Kaila Wilson, MS, CGC. Elyssa Zukin, MS, CGC, Suzie Shehayeb, MS, CGC, Sandra Dreike, MS, CGC, Ilana Solomon, ScM, CGC, Christina Rybak, MS, CGC, Feighanne Hathaway, MS, CGC, Rachelle Mannookian

10:55am-11:05am
Break

11:05am-12:05pm
Putting It All Together: Team-Based Learning (TBL) Part 2: Case Review and Discussion

Faculty Panel: Jane Churpek, MD, MS, Christopher Reilly, MD, Lauren Banaszak, MD, Lucy Godley, MD, Raymond Kim, MD, and Brittany Stewart, MS, CGC

12:05pm-12:10pm
Summary/Closing Remarks

12:05pm-2:00pm
Break

12:30pm-1:30pm
Non-CME Product Theater: TBD
Location: Hemingway

2:00pm-2:20pm
Opening Remarks & Historical Perspective on the Evolution of Cancer Genetics
Cancer Center Director: Kunle Odunsi, MD, PhD

Session 1: Genetic Testing is Getting More Complicated! Specimens and Technologies

Moderators: Sulin Wu, MD, PhD & Feighanne Hathaway, MS, CGC
Location: Grand Ballroom

2:20pm-2:50pm
Leveraging Artificial Intelligence for Automated Interpretation of Cancer Gene Variants
Jeremy Segal, MD

2:50pm-3:20pm
Keynote Address I: Solving Difficult Variants with New Specimens and Technologies Long-read Sequencing, Paired Tumor, RNA Testing
Tom Walsh, PhD

3:20pm-3:50pm
Mutation Signatures as Clues to the Underlying Gene: HRD & MSI
Kara Maxwell, MS

3:50pm-4:20pm
Complexities of Comprehensive Risk Assessment, Test Interpretation and Cancer Risk Management: NCCN Guidelines
Tuya Pal, MD

4:20pm-5:00pm
Great Debate: Should VUS be Clinically-reported?
Heather Hampel, MS and Colin Pritchard, MD

5:00pm-5:15pm
Question & Answer Panel Discussion

5:15pm-7:00pm
Welcome Reception & Poster Session
Location: Renaissance Ballroom

7:30pm
Faculty Dinner

Friday, April 24, 2026

7:00am-7:50am
Non-CME Product Theater: TBD
Location: Hemingway

Session 2: 30+ years after BRCA1 and BRCA2 Discoveries – Lessons Learned about Menopause and Survivorship

Moderators: Lorraine Canham, MD & Rodrigo Guindalini, MD
Location: Grand Ballroom

8:00am-8:10am
Welcome and Announcements

8:10am-8:35am
Taking Care of Women Across the Lifespan – Birth Control and Fertility Issues
Nicole Edison, MD

8:35am-8:55am
Update on Risk Reducing Surgeries
Nora Jaskowiak, MD

8:55am-9:15am
Hormonal Therapy & Transgender Care
Iris Romero, MD

9:15am-9:45am
Keynote Address II: Hormone Replacement Therapy in HBOC Patients
and Long-Term Outcomes
Joane Kotsopoulos, PhD

9:45am-10:00am
Question & Answer Panel Discussion
Panelists: Nicole Edison, MD, Nora Jaskowiak, MD, Iris Romero, MD, & Joane Kotsopoulos, PhD

10:00am-11:00am
Voices of Patient Advocates (Panel)
Moderators: Lisa Madlensky, PhD, CGC and Olufunmilayo Olopade, MD
Panelists: Kathy Baker, Ricki Fairley, Joelle Kaufman, & Anna Woodard, PhD

11:00am-11:15am
Break

Session 3: Transforming Hematology/Oncology Care through Genetics

Moderators: Daniel Arber, MD & Stacy Gray, MD, AM
Location: Grand Ballroom

11:15am-12:00pm
Dr. Harvey Golomb Distinguished Lectureship in Cancer Genetics
Ashok Venkitaraman, MD, PhD

12:00pm-12:20pm
Update on Cancer Genetics Education Across the Globe
Charles Balch, MD

12:20pm-12:40pm
Young Onset Lung Cancer
Marina Garassino, MD

12:40pm-1:00pm
Question & Answer Panel Discussion
Panelists: Ashok Venkitaraman, MD, PhD, Charles Balch, MD, Marina Garassino, MD

1:00-2:00 PM
Lunch

1:10pm-1:50pm
Non-CME Product Theater: TBD
Location: Hemingway

Session 4: Case Presentations with Interprofessional Panel Discussions

Moderators: Jane Churpek, MD, MS & Bita Nehoray, MS, CGC
Location: Grand Ballroom

2:00pm-3:30pm
Case Presentations with Interprofessional Panel Discussions Focused on Incorporating Germline and Somatic Genetic Data into Patient Risk Management and Precision Cancer Treatment

Panel: Colin Pritchard, MD, PhD, Kara Maxwell, MD, PhD, Heather Hampel, MS, CGC, Pamela Ganschow, MD, Elias Obeid, MD, MPH, Michael Hall, MD

Moderators: Bita Nehoray, MS, CGC, Lauren Gima, MS, CGC, Suzie Shehayeb,MS, CGC, Sandra Dreike,MS, CGC, Ilana Solomon, MS, CGC, Christina Rybak, MS, CGC, Elyssa Zuken, MS, CGC, Elise Sobotka, MS, CGC,

Session 5: 30+ years after BRCA1 and BRCA2 Discoveries – Lessons learned from Management of Multiple Cancers

Moderators: Emma Sass and Elias Obeid, MD, MPH
Location: Grand Ballroom

3:30pm-4:00pm
Keynote Address III: Breast Cancer Information Core 30+ years of Curation to Advance HBOC Cure
Lawrence Brody, PhD

4:00pm-4:25pm
Precision Oncology to Impact Men’s Health
Ari Rosenberg, MD

4:25pm-4:45pm
Parp Inhibitors in Hematology
Michael Drazer, MD, PhD

4:45pm-5:00pm
Question & Answer Panel Discussion
Panelists: Lawrence Brody, PhD, Ari Rosenberg, MD, & Michael Drazer, MD, PhD

5:00pm-5:45pm
Breakout Sessions Late Breaking Topics

Room Topic: Innovations in High Risk Screening
Kirti Kulkarni, MD & Milica Medved, PhD, DAPMB
Moderators: Greg Karczmar, PhD, and Cara Essling, MMSPA

Room Topic: High Risk Breast & Prostate Cancer
Elias Obeid, MD, MPH & Joanne Jeter, MD
Moderator: Iris Romero, MD and Sulin Wu, MD, PhD

Room Title: Breast Cancer Prevention Studies: Challenges & Opportunities
Adetunji Toriola, MD, PhD & Jeffrey Weitzel, MD
Moderator: Rodrigo Guindalini, MD and Wenji Guo, MD, PhD

5:45pm
Adjourn

7:00pm
Gala

Saturday, April 25, 2026

7:00am-7:50am
Non-CME Product Theater: TBD
Location: Hemingway

Session 6: AI Integration into Oncology Care

Moderator: Julie Johnson, PhD, MPH, RN and Subomi Omoleye, MD
Location: Grand Ballroom

8:10am-8:35am
Harnessing AI for Risk Stratification and Precision Treatment in Breast Cancer
Frederick Howard, MD

8:35am-9:00am
Population Risk Stratification using SNPs and Mammographic AI
Jeffrey Tice, PhD

9:00am-9:25am
AI in Mammography Screening: Are We There Yet?
Randy Miles, MD

9:25am-9:55am
Keynote Address V: Multi-Omics Approach to Breast Cancer Risk Prediction
Adam Yala, PhD

9:55am-10:15am
Question & Answer Panel Discussion

Panelists: Frederick Howard, MD, Jeffrey Tice, PhD, Randy Miles, MD, & Adam Yala, PhD

10:15am-10:45am
Break

Session 7: Accelerating Progress in Early Detection & Cancer Interception

Moderators: Jan-Marie McEvilly, RN, MS, OCN & Pamela Ganschow, MD
Location: Grand Ballroom

10:45am-11:05am
Contralateral Breast Cancer Risk in Women with PALB2-Associated Breast Cancer
Kelly Metcalfe, RN, PhD

11:05am-11:30am
Keynote Address VI: Communicating Health Risks to Women: Lessons from the United Kingdom
Itunu Johnson-Sogbetun, MBBS

11:30am-11:50am
GLP-1 Therapies: Emerging Evidence from Weight Loss to Disease Management
Silvana Pannain, MD

11:50am-12:30pm
Question & Answer Panel Discussion

12:30-1:45 PM
Lunch

12:45pm-1:30pm
Non-CME Product Theater: TBD
Location: Hemingway

Session 8:
Will Immuno Oncology Accelerate Cures In High Risk Populations:
Technology, Testing, Treatment

Moderators: Christine Drogan, MS, CGC & Lorraine Canham, MD
Location: Grand Ballroom

1:45pm-2:05pm
Vaccines for Women's Cancer: Lessons Learned
Nita Lee, MD, MPH

2:05pm-2:40pm
Keynote Address VII: Immuno Oncology Update for Lynch Syndrome Cancers: Successes and Failures
Michael Hall, MD

2:40pm-3:00pm
Rapid Fire Sessions
Moderator: Lisa Madlensky, PhD, CGC and Michael Drazer, MD, PhD
(podium presentations from selected abstract submissions)

3:00pm-3:15pm
Break

Session 9: Expanding Infrastructure to Implement Biomarker Informed Clinical Trials and Precision Oncology at Scale

Moderators: Jeffrey Weitzel, MD and Michael Mullane, MD
Location: Grand Ballroom

3:15pm-3:35pm
Implementation Science to Expand Navigational Services for Precision Oncology
Ted Skolarus, MD

3:35pm-3:55pm
VHL Center of Excellence: Implications of germline findings in Renal Cell Carcinoma
Jonathan Trujillo, MD, PhD

3:55pm-4:15pm
Developing a Center of Excellence for Women's Cancers in Ontario Canada
for Impact across the Globe
Steven Narod, MD

4:15pm-5:00pm
Wrap Up: The Future of Cancer Interception Studies
Judy Garber, MD, MPH and Olufunmilayo Olopade, MD